Summary
Daewoong Pharmaceutical Co Ltd (Daewoong Pharma) is one of the leading manufacturers and distributors of prescription drugs in South Korea. It offers prescription drugs, quasi drugs, medical devices, cosmetics, health foods and APIs. The company produces products in the forms of tablets, capsules, ointments, injections, liquids and sprays. It offers its products for the therapeutic conditions of bone and joint diseases, cardiovascular diseases, central nervous system diseases, circulatory system, dermatological, gastrointestinal, and respiratory remedies, among others. The company also carries out development and commercialization of products through in-licensing, co-marketing and co-promotion. It operates across Asia including Indonesia, China, Vietnam, Thailand and India; and the US. Daewoong Pharma is headquartered in Seoul, South Korea.
Daewoong Pharmaceutical Co Ltd (069620) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Daewoong Pharma Enters into Agreement with AstraZeneca 11
Daiichi Sankyo Enters into Co-Marketing Agreement with Daewoong Pharma 11
CrystalGenomics Enters into Co-Marketing Agreement with Daewoong Pharma 12
Daewoong Pharma Enters into R&D Agreement with Riken 13
Daewoong Pharma and Astellas Pharma Korea Enter into Agreement 13
Daiichi Sankyo Enters into Co-Promotion Agreement with Daewoong Pharma For Olostar 14
Abdi Ibrahim Enters into Distribution Agreement with Daewoong Pharma 15
Ilyang Pharma Enters Into Co-Marketing Agreement With Daewoong Pharma For Supect 16
Merck Enters Into Co-Promotion Agreement With Daewoong Pharma For Vytorin 16
Medivir Enters Into Distribution Agreement With Daewoong Pharma For Xerclear 17
Licensing Agreements 18
Daewoong Pharma Enters into Licenisng Agreement with Eleison Pharma 18
Daewoong Pharma Enters into Licensing Agreement with 3-D Matrix Asia 19
BioAlliance Pharma Enters Into Licensing Agreement With Daewoong Pharma For Sitavig 20
Alphaeon Enters Into Licensing Agreement With Daewoong Pharma For Botulinum Toxin Type A Product 21
Medivir Terminates Licensing Agreement With Daewoong Pharma For MIV-210 21
Affibody Enters into Licensing Agreement with Daewoong Pharma for Albumod 22
Daewoong Enters Into Licensing Agreement With Ipsen Tianjin For Smecta Technology 23
Daewoong Pharma Enters Into Licensing Agreement With Egyptian Technologies For Easyef 24
Almirall Enters Into Licensing Agreement With Daewoong Pharma For Aclidinium 25
Antares Pharma Enters Into Licensing Agreement With Daewoong Pharma For Oxybutynin Gel 26
Ampio Pharma Enters Into Licensing Agreement With Daewoong Pharma For Zertane 27
Acquisition 28
Daewoong Pharma To Acquire Liaoning Baifeng, Drug Manufacturer, For US$16 Million 28
Daewoong Pharmaceutical Co Ltd - Key Competitors 30
Key Employees 31
Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 34
Legal and Regulatory 34
May 26, 2016: Daewoong Bio ‘UDCA’ passes EDQM (European Directorate for the Quality of Medicines & Healthcare) inspection 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List of Tables
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Daewoong Pharmaceutical Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Daewoong Pharma Enters into Agreement with AstraZeneca 11
Daiichi Sankyo Enters into Co-Marketing Agreement with Daewoong Pharma 11
CrystalGenomics Enters into Co-Marketing Agreement with Daewoong Pharma 12
Daewoong Pharma Enters into R&D Agreement with Riken 13
Daewoong Pharma and Astellas Pharma Korea Enter into Agreement 13
Daiichi Sankyo Enters into Co-Promotion Agreement with Daewoong Pharma For Olostar 14
Abdi Ibrahim Enters into Distribution Agreement with Daewoong Pharma 15
Ilyang Pharma Enters Into Co-Marketing Agreement With Daewoong Pharma For Supect 16
Merck Enters Into Co-Promotion Agreement With Daewoong Pharma For Vytorin 16
Medivir Enters Into Distribution Agreement With Daewoong Pharma For Xerclear 17
Daewoong Pharma Enters into Licenisng Agreement with Eleison Pharma 18
Daewoong Pharma Enters into Licensing Agreement with 3-D Matrix Asia 19
BioAlliance Pharma Enters Into Licensing Agreement With Daewoong Pharma For Sitavig 20
Alphaeon Enters Into Licensing Agreement With Daewoong Pharma For Botulinum Toxin Type A Product 21
Medivir Terminates Licensing Agreement With Daewoong Pharma For MIV-210 21
Affibody Enters into Licensing Agreement with Daewoong Pharma for Albumod 22
Daewoong Enters Into Licensing Agreement With Ipsen Tianjin For Smecta Technology 23
Daewoong Pharma Enters Into Licensing Agreement With Egyptian Technologies For Easyef 24
Almirall Enters Into Licensing Agreement With Daewoong Pharma For Aclidinium 25
Antares Pharma Enters Into Licensing Agreement With Daewoong Pharma For Oxybutynin Gel 26
Ampio Pharma Enters Into Licensing Agreement With Daewoong Pharma For Zertane 27
Daewoong Pharma To Acquire Liaoning Baifeng, Drug Manufacturer, For US$16 Million 28
Daewoong Pharmaceutical Co Ltd, Key Competitors 30
Daewoong Pharmaceutical Co Ltd, Key Employees 31
Daewoong Pharmaceutical Co Ltd, Other Locations 32
Daewoong Pharmaceutical Co Ltd, Subsidiaries 32List of Figures
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
